首页> 外文期刊>Materials science & engineering, C. Materials for Biogical applications >Peptide functionalized poly ethylene glycol-poly caprolactone nanomicelles for specific cabazitaxel delivery to metastatic breast cancer cells
【24h】

Peptide functionalized poly ethylene glycol-poly caprolactone nanomicelles for specific cabazitaxel delivery to metastatic breast cancer cells

机译:肽官能化聚乙二醇 - 聚己内酯纳米甲基纳米Cabazitaxel递送给转移性乳腺癌细胞

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Abstract Metastatic cancer is responsible for 90% of deaths in world. Usage of nano-carriers improve the delivery and efficacy of chemotherapeutic agents. Recent studies suggest that decoration of the surface of nano-carriers with various targeting agents may further improve their overall therapeutic efficacy. Using specified peptides in targeted drug delivery is a key point in recent researches. In this study, tumor metastasis targeting (TMT) homing peptide was applied as a targeting group to improve specific drug delivery to tumor cells. TMT peptide is conjugated to poly ethylene glycol-poly caprolactone (PEG-PCL) micellar nanoparticles as carriers for targeted delivery of cabazitaxel to metastatic breast cancer cells. Synthesis of PEG-PCL copolymer was performed by amidation reaction between carboxylic acid group of PEG and amine group of PCL. Nanomicelles were prepared via solvent evaporation method. TMT peptide was covalently conjugated onto nanomicelles through the amine group of PEG. TMT-PEG-PCL nanoparticles were analyzed by Fourier transform infrared spectroscopy (FTIR), scanning electron microscope (SEM), dynamic light scattering (DLS), gel permeation chromatography (GPC) and nuclear magnetic resonance (NMR). Toxicity and cellular uptake of nanomicelles were investigated by in vitro cytotoxicity assays and confocal scanning microscopy in MCF-7 (non-metastatic breast cancer cells) and MDA-MB-231 (metastatic breast cancer cells). The final nanomicelles had about 110nm mean size and encapsulation efficiency of 82.5%. Treatment of metastatic breast cancer cells with targeted nanomicelles significantly increased the necrosis
机译:<![cdata [ 抽象 转移性癌症是世界上90%的死亡人员。纳米载体的用途改善了化学治疗剂的输送和功效。最近的研究表明,具有各种靶向剂的纳米载体表面的装饰可以进一步提高其总治疗效果。在靶向药物递送中使用指定的肽是最近研究的关键点。在该研究中,将靶向靶向(TMT)靶向(TMT)络肽作为靶向基团施用,以改善对肿瘤细胞的特定药物递送。 TMT肽与聚乙二醇 - 聚己内酯(PEG-PCL)胶束纳米颗粒作为载体缀合,作为用于转移乳腺癌细胞的Cabazitaxel的靶向递送。通过PEG和胺基的羧酸基团与PCL的羧酸基团之间的酰胺化反应进行PEG-PCL共聚物的合成。通过溶剂蒸发方法制备纳米核。将TMT肽通过PEG的胺基共价缀合至纳米钙。通过傅里叶变换红外光谱(FTIR),扫描电子显微镜(SEM),动态光散射(DLS),凝胶渗透色谱(GPC)和核磁共振(NMR)分析TMT-PEG-PCL纳米颗粒。通过体外细胞毒性测定和MCF-7(非转移乳腺癌细胞)和MDA-MB-231(转移乳腺癌细胞)的共聚焦扫描显微镜研究了纳米钙的毒性和细胞摄取。最终的纳米钙有约110 Nm平均尺寸和封装效率为82.5%。用靶向纳米切征治疗转移性乳腺癌细胞显着增加了坏死

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号